Načítá se...

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.

The pharmacokinetics of cidofovir (HPMPC; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine) were examined at five dose levels in three phase I/II studies in a total of 42 human immunodeficiency virus-infected patients (with or without asymptomatic cytomegalovirus infection). Levels of cidofovir...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cundy, K C, Petty, B G, Flaherty, J, Fisher, P E, Polis, M A, Wachsman, M, Lietman, P S, Lalezari, J P, Hitchcock, M J, Jaffe, H S
Médium: Artigo
Jazyk:Inglês
Vydáno: 1995
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC162721/
https://ncbi.nlm.nih.gov/pubmed/7574510
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!